Repligen (RGEN) Total Current Liabilities (2011 - 2026)
Repligen's (RGEN) quarterly Total Current Liabilities came in at $132.7 million in Q2 2026, up 7.84% year-over-year from $123.0 million in Q2 2025, and up 5.11% quarter-over-quarter from $126.2 million in Q1 2026.
Analysis
Repligen (RGEN) Total Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Total Current Liabilities for 16 consecutive years, with $132.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 7.84% year-over-year to $132.7 million in Q2 2026; TTM through Jun 2026 was $132.7 million, a 7.84% increase from a year earlier, with the FY2025 full-year figure at $135.8 million, up 7.13% from the prior year.
- Total Current Liabilities was $132.7 million for Q2 2026 at Repligen, up from $126.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $424.3 million in Q1 2022 and troughed at $108.4 million in Q3 2024.
- A 5-year average of $244.7 million and a median of $169.9 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 35.43% in 2022 and slumped 71.4% in 2024, its largest moves.
- Over 5 years, Total Current Liabilities stood at $404.2 million in 2022, then plunged by 59.19% to $164.9 million in 2023, then decreased by 23.13% to $126.8 million in 2024, then grew by 7.13% to $135.8 million in 2025, then declined by 2.33% to $132.7 million in 2026.
- The last three Total Current Liabilities figures came in at $132.7 million (Q2 2026), $126.2 million (Q1 2026), and $135.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 2.29 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 1.58 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 1.28 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 163.70 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 961.30 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 132.66 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 118.51 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 1.20 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132.66 Mn |
| Mar 31, 2026 | 126.21 Mn |
| Dec 31, 2025 | 135.83 Mn |
| Sep 30, 2025 | 131.14 Mn |
| Jun 30, 2025 | 123.01 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Dec 31, 2024 | 126.79 Mn |
| Sep 30, 2024 | 108.37 Mn |
| Jun 30, 2024 | 174.81 Mn |
| Mar 31, 2024 | 181.55 Mn |
| Dec 31, 2023 | 164.94 Mn |
| Sep 30, 2023 | 378.94 Mn |
| Jun 30, 2023 | 388.35 Mn |
| Mar 31, 2023 | 416.56 Mn |
| Dec 31, 2022 | 404.20 Mn |
| Sep 30, 2022 | 410.70 Mn |
| Jun 30, 2022 | 423.52 Mn |
| Mar 31, 2022 | 424.33 Mn |
| Dec 31, 2021 | 375.26 Mn |
| Sep 30, 2021 | 349.44 Mn |